Skin samples collection from subjects with atopic dermatitis in Japan and in-vitro analyses

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030220204

Enrollment

Registered

2022-07-08

Start date

2022-07-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Age between 20 to 75 years -Subject has confirmed clinical diagnosis of active AD according to Hanifin and Rajka criteria with at least 6-month history

Exclusion criteria

Exclusion criteria: -Subjects with presence of active skin infection (viral, bacterial or fungal in nature) and/or systemic infection requiring treatment with systemic or topical antimicrobial agents and/or a skin drainage procedure. -Other active or recurrent concomitant skin conditions (e.g., psoriasis, allergic or irritant contact dermatitis) that could affect assessment of AD lesions and the bacteria involved and may interfere with the clinical assessment as assessed by the investigator.

Design outcomes

Primary

Measure	Time frame
The effectiveness of Compound X on isolated bacteria	—

Contacts

Public Contact- Clinical Trials Information

Maruho Co.,Ltd. Kyoto R&D Center

ctinfo@mii.maruho.co.jp+81-75-325-3279

Outcome results